A. Wayne

发表

Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease.

K. Baird, A. Wayne, 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantation.

Allen R. Chen, S. Steinberg, M. Borowitz, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.

S. Pittaluga, M. Sabatino, D. Kleiner, 2015, Blood.

Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.

Susan E Abbatiello, Susan E. Abbatiello, Thomas P Conrads, 2008, Journal of proteomics.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies.

N. Kröger, P. Hari, M. Bishop, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

First International Workshop on the Biology , Prevention and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation : Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

E. Estey, D. Porter, K. Peggs, 2010 .

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

E. Estey, D. Maloney, D. Porter, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

disease: a 28-year experience in the United States Characterization and treatment of chronic active Epstein-Barr virus

W. Wilson, E. Jaffe, S. Pittaluga, 2011 .

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

W. Wilson, E. Jaffe, S. Pittaluga, 2011, Blood.

Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

C. Bollard, M. Cairo, B. Alobeid, 2011, Bone Marrow Transplantation.

Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates.

I. Pastan, D. Fitzgerald, R. Kreitman, 2011, Cancer research.

Integrin α6 mediates drug resistance of acute lymphoblastic B-cell leukemia.

T. Graeber, M. Oberley, N. Heisterkamp, 2020, Blood.

Managing therapy-associated neurotoxicity in children with ALL.

R. Bansal, D. Bhojwani, A. Wayne, 2021, Hematology. American Society of Hematology. Education Program.

Hematopoietic stem cell transplantation for leukemia.

R. Egeler, K. Baird, A. Wayne, 2010, Pediatric clinics of North America.

Response Assessment and Post–CAR T-Cell Therapy Management

M. Pulsipher, A. Taraseviciute, A. Wayne, 2020 .

Cells to prevent/treat relapse following allogeneic stem cell transplantation.

A. Wayne, A. Dietz, 2017, Hematology. American Society of Hematology. Education Program.

Immunogenicity of CAR T cells in cancer therapy

C. Turtle, M. Pulsipher, Mohamad Hamieh, 2021, Nature Reviews Clinical Oncology.

Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design

I. Pastan, A. Wayne, F. Müller, 2016, Clinical Cancer Research.

Results from an international phase 2 study of the anti‐CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B‐lineage acute lymphoblastic leukemia

I. Pastan, A. Baruchel, F. Locatelli, 2020, Pediatric blood & cancer.

CAR T-cell product performance in haematological malignancies before and after marketing authorisation.

B. Levine, A. Wayne, M. Abou-el-Enein, 2020, The Lancet. Oncology.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction.

N. Kröger, M. Bishop, S. Giralt, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: Diagnostic and therapeutic challenges

M. Bishop, M. Stetler-Stevenson, D. Arthur, 2012, American journal of hematology.

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.

N. Kröger, D. Porter, C. June, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The American Society of Pediatric Hematology/Oncology workforce assessment: Part 2—Implications for fellowship training

P. Leavey, C. Dandoy, S. Badawy, 2018, Pediatric blood & cancer.

Vulvovaginal Chronic Graft-Versus-Host Disease With Allogeneic Hematopoietic Stem Cell Transplantation

M. Turner, M. Bishop, R. Childs, 2007, Obstetrics and gynecology.

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study

M. Sulis, M. Hermiston, A. Place, 2018, Leukemia.

Characterization of CD22 expression in acute lymphoblastic leukemia

I. Pastan, R. Kreitman, C. Yuan, 2015, Pediatric blood & cancer.

New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL

M. Pulsipher, K. Schultz, A. Wayne, 2014, Bone Marrow Transplantation.

Immunotoxins for leukemia.

I. Pastan, R. Kreitman, A. Wayne, 2014, Blood.

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Seth M Steinberg, Marianna Sabatino, S. Steinberg, 2015, The Lancet.

Protein Kinase Inhibitor H89 Enhances the Activity of Pseudomonas Exotoxin A–Based Immunotoxins

I. Pastan, A. Wayne, Xiu-fen Liu, 2016, Molecular Cancer Therapeutics.

ProteinKinase InhibitorH 89 Enhances theActivity of Pseudomonas ExotoxinA – Based Immunotoxins

I. Pastan, A. Wayne, Xiu-fen Liu, 2016 .

Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia

I. Pastan, R. Beers, T. Bera, 2018, Toxins.

Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias

B. Widemann, N. Jayaprakash, M. Merchant, 2016, Pediatric blood & cancer.

Anti-CD 22 Immunotoxin RFB 4 ( dsFv )-PE 38 ( BL 22 ) for CD 22-Positive Hematologic Malignancies of Childhood : Preclinical Studies and Phase I Clinical Trial

S. Steinberg, I. Pastan, H. Findley, 2010 .

NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic

J. Vose, J. Radich, N. Kröger, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial

S. Steinberg, I. Pastan, H. Findley, 2010, Clinical Cancer Research.

Allogeneic hematopoietic stem cell transplantation for myeloproliferative disorders and myelodysplastic syndromes.

A. Wayne, A. Barrett, Alan S. Wayne, 2003, Hematology/oncology clinics of North America.

Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting

R. Sposto, P. Gaynon, A. Wayne, 2017, Pediatric hematology and oncology.

A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene*

I. Pastan, O. Chertov, Laiman Xiang, 2013, The Journal of Biological Chemistry.

Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.

H. Kantarjian, S. O'brien, Deborah A. Thomas, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy

I. Pastan, O. Chertov, Laiman Xiang, 2012, Proceedings of the National Academy of Sciences.

Cytotoxicity of the anti‐CD22 immunotoxin HA22 (CAT‐8015) against paediatric acute lymphoblastic leukaemia

D. Campana, S. Steinberg, I. Pastan, 2010, British journal of haematology.

Progress in the curative treatment of childhood hematologic malignancies.

L. Helman, G. Reaman, A. Wayne, 2008, Journal of the National Cancer Institute.

Variables affecting the quantitation of CD22 in neoplastic B cells

G. Marti, D. Venzon, I. Arun, 2011, Cytometry. Part B, Clinical cytometry.

Application of immunotherapy in pediatric leukemia

A. Wayne, 2009, Current hematologic malignancy reports.

R. Sposto, Weili Sun, S. Rheingold, 2016, Pediatric blood & cancer.

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox: Phase I Study in Pediatric Acute Lymphoblastic Leukemia (ALL)

C. Pui, I. Pastan, L. Silverman, 2011 .

Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.

A. Barrett, M. Bishop, R. Childs, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloid lineage switch following chimeric antigen receptor T‐cell therapy in a patient with TCF3‐ZNF384 fusion‐positive B‐lymphoblastic leukemia

M. Oberley, G. Raca, P. Gaynon, 2018, Pediatric blood & cancer.

Disease detection methodologies in relapsed B‐cell acute lymphoblastic leukemia: Opportunities for improvement

M. Stetler-Stevenson, T. Fry, C. Mackall, 2020, Pediatric blood & cancer.

Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy.

S. Fischer, J. Cohen, K. Baird, 2008, The Pediatric infectious disease journal.

Real‐world experience in treating pediatric relapsed/refractory or therapy‐related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium

S. Hilsenbeck, E. Jo, D. Bhojwani, 2022, Pediatric blood & cancer.

Barriers to bone marrow transplantation for sickle cell anemia.

J. Scott, K. Sullivan, R. Storb, 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antidepressant treatment of Medicaid‐insured youth with a cancer diagnosis

E. Ballard, D. Mattison, D. Safer, 2012 .

Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia

C. Stratakis, J. Toretsky, D. Arthur, 2010, Pediatric blood & cancer.

Pediatric Clinics of North America: Hematopoietic Stem Cell Transplantation Stem Cell Transplantation for Leukemia

K. Baird, A. Wayne, 2010 .

ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006 .

Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study

Byunggil Yoo, M. Sulis, M. Hermiston, 2020, Clinical Cancer Research.

In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia

Mo Yang, D. Bhojwani, Hsiao-Chuan Liu, 2021, Experimental and Therapeutic Medicine.

Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.

E. Jaffe, C. Alvarado, S. Horwitz, 2012, Clinical lymphoma, myeloma & leukemia.

Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma

W. Wilson, I. Pastan, T. Kipps, 2007, Leukemia.

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia.

I. Pastan, L. Silverman, J. Whitlock, 2017, Blood.

Phase I Study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia.

I. Pastan, L. Silverman, J. Whitlock, 2017, Blood.

Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8.

I. Pastan, O. Chertov, Laiman Xiang, 2013, Leukemia research.

Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.

S. Pittaluga, K. Heselmeyer-Haddad, C. Kesserwan, 2012, The Journal of allergy and clinical immunology.

Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells

M. Fabbri, A. Jong, R. Seeger, 2017, Journal of extracellular vesicles.

Psychotropic medication use in pediatric patients with cancer.

E. Ballard, D. Rosenstein, L. Wiener, 2006, Archives of pediatrics & adolescent medicine.

Non-myeloablative allogeneic hematopoietic stem cell transplantation with pre-transplant immune depletion results in rapid full donor engraftment in pediatric patients with malignancy

M. Bishop, T. Fry, C. Mackall, 2004 .

Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

A. Baruchel, M. Hermiston, B. K. Masouleh, 2022, Haematologica.

Feasibility of treating post-transplantation minimal residual disease in children with acute leukemia.

Allen R. Chen, M. Borowitz, N. Shah, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pediatric large‐volume leukapheresis: a single institution experience with heparin versus citrate‐based anticoagulant regimens

C. Mackall, H. Malech, S. Leitman, 2004, Transfusion.

Abnormal bone marrow histopathology in paediatric mastocytosis

D. Metcalfe, I. Maric, A. Wayne, 2015, British journal of haematology.

The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL

N. Heisterkamp, M. Konopleva, D. Bhojwani, 2017, Cancers.

Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature.

R. Arceci, J. Whitlock, J. Lipton, 1999, Medical and pediatric oncology.

Sibling stem cell donor experiences at a single institution

T. Fry, L. Wiener, A. Wayne, 2008, Psycho-oncology.

Hematopoietic Stem Cell Donation in Children

T. Fry, L. Wiener, A. Wayne, 2007, Journal of psychosocial oncology.

The transfusion of neutrophil‐specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions

D. Stroncek, H. Klein, S. Leitman, 2007, Transfusion.

Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome.

W. Gahl, M. Gunay‐Aygun, S. Y. Kim, 2005, Molecular genetics and metabolism.

Pretransplant MRD: the light is yellow, not red.

J. Radich, A. Wayne, 2012, Blood.

Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain.

J. Lippincott-Schwartz, A. Barrett, J. Gillette, 2012, Blood.

Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.

Aaron R Cooper, O. Yang, D. Gjertson, 2012, Blood.

Survival in Medically Treated Patients with Homozygous β-Thalassemia

J. H. MacMillan, G. Koren, N. Olivieri, 1994 .

Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease

A. Barrett, K. Csaky, M. Bishop, 2004, Bone Marrow Transplantation.

Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database.

T. Fears, M. Tucker, J. Strouse, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Simplified process for the production of anti-CD19-CAR-engineered T cells.

Crystal Mackall, Marianna Sabatino, M. Sabatino, 2013, Cytotherapy.

Chimeric Antigen Receptor (CAR) T Cells

Daniel W. Lee, A. Wayne, 2015 .

Phase I Clinical Trial of the Anti-CD22 Immunotoxin CAT-8015 (HA22) for Pediatric Acute Lymphoblastic Leukemia (ALL).

C. Pui, I. Pastan, M. Stetler-Stevenson, 2009 .

Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells

M. Fabbri, A. Jong, R. Seeger, 2019, Journal of extracellular vesicles.

Survival in medically treated patients with homozygous beta-thalassemia.

J. H. MacMillan, G. Koren, N. Olivieri, 1994, The New England journal of medicine.

Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.

I. Pastan, D. Dimitrov, R. Morgan, 2013, Blood.

Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease.

C. Pegelow, J. Scott, K. Sullivan, 2000, Blood.

D. Landau, Catherine J. Wu, N. Kröger, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance

P. Gaynon, Weili Sun, C. Fu, 2016, Journal of pediatric hematology/oncology.

Thromboembolic events in children and young adults with pediatric sarcoma.

L. Helman, C. Mackall, A. Wayne, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphoma: Burkitt's and lymphoblastic lymphomas

A. Rosenwald, W. Wilson, G. Ott, 2007 .

Improving access to novel agents for childhood leukemia

R. Sposto, P. Gaynon, Weili Sun, 2015, Cancer.

Clonality in juvenile chronic myelogenous leukemia.

D. Gilliland, J. Prchal, L. Busque, 1995, Blood.

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods,

J. Vose, J. Radich, N. Kröger, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

E. Jaffe, M. Raffeld, S. Pittaluga, 2010, Haematologica.

A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium.

Peter A. Jones, T. Triche, G. Liang, 2018, Blood.

ANTIBODY DERIVATIVES AS NEW THERAPEUTICS FOR HEMATOLOGIC MALIGNANCIES Immunotoxins for leukemia

I. Pastan, R. Kreitman, A. Wayne, 2014 .

Immunotherapy for Pediatric Leukemia

N. Shah, A. Wayne, H. Dave, 2013, Front. Oncol..

Immunotherapy of childhood cancer: from biologic understanding to clinical application

C. Mackall, C. Capitini, A. Wayne, 2010, Current opinion in pediatrics.

Immune-based therapeutics for pediatric cancer

C. Mackall, C. Capitini, A. Wayne, 2010, Expert opinion on biological therapy.

Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.

Allen R. Chen, M. Horowitz, R. Gale, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

M. Sulis, L. Silverman, J. Whitlock, 2022, Haematologica.

Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.

S. Steinberg, M. Bishop, T. Fry, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The American Society of Pediatric Hematology/Oncology workforce assessment: Part 1—Current state of the workforce

S. Badawy, J. Hilden, A. Wayne, 2018, Pediatric blood & cancer.

The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.

W. Wilson, S. Steinberg, E. Jaffe, 2010, Blood.

Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working Group

M. Sulis, S. Izraeli, B. Chang, 2017, Pediatric hematology and oncology.

Biological roles and potential applications of immune cell-derived extracellular vesicles

Muller Fabbri, Chuan Wen, Ambrose Y. Jong, 2017, Journal of extracellular vesicles.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.

N. Kröger, D. Porter, M. Bishop, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies

J. Khan, M. Anver, P. Brown, 2012, PloS one.

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

N. Kröger, D. Porter, C. June, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox

I. Pastan, M. Cam, Chin-Hsien Tai, 2018, Proceedings of the National Academy of Sciences.

Targeting HLA-DR Loss in Hematologic Malignancies with an Inhibitory Chimeric Antigen Receptor.

A. Wayne, Jianming Xie, Fan Fei, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation

N. Kröger, S. Giralt, A. Wayne, 2018, Bone Marrow Transplantation.

Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells

M. Sabatino, B. Levine, C. Civin, 2011, Journal of immunotherapy.

Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.

M. Raffeld, D. Stroncek, T. Fry, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates

B. Widemann, K. Warren, N. Shah, 2016, Investigational New Drugs.

Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders

K. Sullivan, R. Storb, W. Leisenring, 1997 .

Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.

J. Scott, K. Sullivan, W. Leisenring, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium

M. Hermiston, A. Place, R. Sposto, 2022, American journal of hematology.

Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents.

B. Korf, R. Macklis, H. Grier, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Empiric Antifungal Therapy for the Neutropenic Patient

S. Chanock, T. Walsh, A. Groll, 2001 .

Is another antibody conjugate against ALL needed?

C. Pui, A. Wayne, 2015, The Lancet. Haematology.

Modified manufacturing process modulates CD19CAR T-cell engraftment fitness and leukemia-free survival in pediatric and young adult subjects.

M. Jensen, M. Pulsipher, Julie R. Park, 2022, Cancer immunology research.

Lymphocytic interstitial pneumonitis, elevated IgM concentration, and hepatosplenomegaly in ataxia-telangiectasia.

R. Nelson, R. Gatti, C. Langston, 2001, The Journal of pediatrics.

Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre‐transplant minimal residual disease reduction

L. Silverman, B. Wood, J. Whitlock, 2020, Pediatric blood & cancer.

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.

J. Chewning, M. Verneris, M. Qayed, 2020, Blood.

Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells Produce Complete Responses With Acceptable Toxicity But Without Chronic B-Cell Aplasia In Children With Relapsed Or Refractory Acute Lymphoblastic Leukemia (ALL) Even After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

S. Rosenberg, M. Sabatino, M. Stetler-Stevenson, 2013 .

High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias

P. Meltzer, S. Davis, R. Walker, 2010, Leukemia.

IT TAKES A VILLAGE: MAXIMIZING SUPPORTIVE CARE AND MINIMIZING TOXICITY DURING CHILDHOOD LEUKEMIA THERAPY

R. Bansal, D. Bhojwani, A. Wayne, 2021 .

Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.

C. Kesserwan, D. Kohn, F. Candotti, 2011, Blood.

Immune Reconstitution After Gene Therapy (GTx) for Adenosine Deaminase Deficient Severe Combined Immune Deficiency (ADA-SCID)

C. Kesserwan, D. Kohn, L. Muul, 2009 .

Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation

Allen R. Chen, M. Borowitz, N. Shah, 2012 .

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox (HA22, CAT-8015): Activity in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplantation (SCT)

I. Pastan, L. Silverman, J. Whitlock, 2012 .

Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients

W. Wilson, S. Steinberg, E. Jaffe, 2008 .

Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses

M. Jensen, M. Pulsipher, Julie R. Park, 2019, Blood.

Kit Signaling Regulates Mitf Expression in Mastocytosis.

D. Metcalfe, C. Takemoto, R. Kapur, 2006 .

Pharmacokinetics of Intravenous Voriconazole in Obese Patients: Implications of CYP2C19 Homozygous Poor Metabolizer Genotype

R. Danner, B. Moriyama, W. Figg, 2013, Pharmacotherapy.

Children as hematopoietic cell donors in research: when is it approvable?

C. Grady, T. Fry, D. Wendler, 2015, Bone Marrow Transplantation.

Financial analysis of chronic transfusion for stroke prevention in sickle cell disease.

C. Pegelow, A. Wayne, A. Wayne, 2000, Blood.

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

J. V. Stone, J. Klein, J. Wingard, 1999 .

Abstract CT230: Pediatric phase 1 trial of moxetumomab pasudotox: Activity in chemotherapy refractory acute lymphoblastic leukemia (ALL)

I. Pastan, L. Silverman, J. Whitlock, 2014 .

PS962 PHASE 1 RESULTS OF ZUMA-4: KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

A. Baruchel, M. Hermiston, R. Jain, 2019, HemaSphere.

The Addition of Rituximab to Dose-Adjusted EPOCH with HAART Suspension Is Highly Effective and Tolerable in AIDS-Related Lymphoma (ARL) and Allows the Delivery of Abbreviated Chemotherapy.

W. Wilson, S. Steinberg, E. Jaffe, 2005 .

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

S. Steinberg, S. Rosenberg, M. Sabatino, 2015, The Lancet.

Improving access to novel agents for childhood leukemia

R. Sposto, P. Gaynon, Weili Sun, 2015, Cancer.

S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDY

B. Burkhardt, A. Baruchel, M. Hermiston, 2022, HemaSphere.

Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates.

I. Pastan, R. Kreitman, A. Wayne, 2011, Cancer research.

Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease.

K. Baird, A. Wayne, 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Complete Remissions In 3 of 12 Patients with Pediatric Acute Lymphoblastic Leukemia (ALL) During Phase I Testing of the Anti-CD22 Immunotoxin Moxetumomab Pasudotox

C. Pui, I. Pastan, L. Silverman, 2010 .

Early Clinical Experience of aAPC Activated NK-DLI Following Allogeneic PBSCT in Pediatric Solid Tumor Patients.

T. Fry, C. Mackall, K. Baird, 2012 .

Pre-Clinical Evaluation of the Anti-CD22 Immunotoxin CAT-8015 in Combination with Chemotherapy Agents for Childhood B-Precursor Acute Lymphoblastic Leukemia (Pre-B ALL).

I. Pastan, M. Stetler-Stevenson, R. Kreitman, 2007 .

Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737

I. Pastan, Elizabeth Moskatel, R. Kreitman, 2011, Leukemia & lymphoma.